A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders

Ishikawa, Shin‐ichi; Kikuta, Kazuyo; Sakai, Masaaki; Mitamura, Takashi; Motomura, Naoyasu; Hudson, Jennifer L.

doi:10.1016/j.brat.2019.103432

Cited by 25 publications

(39 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is clear that far more extensive investigation is needed to evaluate psychological treatments for child anxiety disorders among more diverse populations and settings, particularly given the promising findings that suggest that children from ethnic minorities (specifically Hispanic/Latino youth in the USA) can obtain similar outcomes to those from the dominant ethnic group (here European Americans), despite lower family incomes (Pina, Silverman, Fuentes, Kurtines, & Weems, 2003). A recent relevant example used bidirectional cultural adaptation to develop the Japanese Anxiety Children/Adolescents CBT (JACA-CBT) programme (Ishikawa et al, 2019), providing initial support for the transportability of CBT to a non-Western culture.…”

Section: Are Treatments Applicable Across Populations/ Settings?mentioning

confidence: 99%

Practitioner Review: Anxiety disorders in children and young people – assessment and treatment

Creswell

Waite

Hudson

2020

Child Psychology Psychiatry

View full text Add to dashboard Cite

Despite significant advancements in our knowledge of anxiety disorders in children and adolescents, they continue to be underrecognised and undertreated. It is critical that these disorders are taken seriously in children and young people as they are highly prevalent, have a negative impact on educational, social and health functioning, create a risk of ongoing anxiety and other mental health disorders across the life span and are associated with substantial economic burden. Yet very few children with anxiety disorders access evidence-based treatments, and there is an urgent need for widespread implementation of effective interventions. This review aimed to provide an overview of recent research developments that will be relevant to clinicians and policymakers, particularly focusing on the development and maintenance of child anxiety disorders and considerations for assessment and treatment. Given the critical need to increase access to effective support, we hope this review will contribute to driving forward a step change in treatment delivery for children and young people with anxiety disorders and their families. Key practitioner messages:Assessment of anxiety disorders should routinely involve valid and reliable interview and questionnaire measures of anxiety disorders and other common comorbid problems.Cognitive behaviour therapy is effective for treating anxiety disorders in children and young people. There is currently insufficient evidence for the effectiveness of any other psychological treatment. There is evidence that SSRIs are effective in the short-medium term, but there is a lack of longer-term evaluation.Few children who could benefit receive treatment for anxiety disorders. Brief guided interventions that can be delivered by nonspecialists are effective for some preadolescent children and provide a means to increase access to psychological interventions, potentially within a stepped care model, but less is known about their effectiveness for adolescents. Anxiety disorders in children and young people 637 Areas for future research:Experimental studies to elucidate (cognitive, behavioural, environmental) maintenance mechanisms of anxiety disorders and how they vary across childhood and adolescence and in particular contexts.Sufficiently large treatment studies to examine predictors, mediators and moderators of treatment to help optimise treatment outcomes and support improvements in personalised care.Use of technology to promote engagement, access, integrity, efficiency and effectiveness of treatments. Comparisons of different treatment approaches that are fully powered to detect meaningful clinical differences, with appropriate control conditions (e.g. including placebo where appropriate).Health economic evaluations to enable health services to increase access by offering the most efficient treatment approaches. Implementation research to maximise application and integrity of evidence-based treatments in routine clinical practice.

show abstract

Section: Are Treatments Applicable Across Populations/ Settings?mentioning

confidence: 99%

Practitioner Review: Anxiety disorders in children and young people – assessment and treatment

Creswell

Waite

Hudson

2020

Child Psychology Psychiatry

View full text Add to dashboard Cite

show abstract

“…However, trials vary in use of (a) child and/or parent interviews; and (b) information provided by one or more informant to assign and report diagnoses and interference/severity ratings. Administering independent child and parent interviews is standard practice and joint parent and child interviews can be more acceptable in specific contexts (Ishikawa et al, 2019). However, there are circumstances where the child or parent interview only is used, for example, because of the specific sample, the purpose of the trial, the age of participants, available resources, or participant burden.…”

Section: Issues and Guidelinesmentioning

confidence: 99%

Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders – an international consensus statement

Creswell

Nauta

Hudson

et al. 2020

Child Psychology Psychiatry

Self Cite

View full text Add to dashboard Cite

Background: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). Methods: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. Results and Conclusions: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward.

show abstract

“…Following a 10‐week treatment, intent‐to‐treat analyses revealed that the PE condition showed a greater decrease than the control condition on post‐traumatic stress disorder and depressive symptoms. Finally, Ishikawa et al (2019) conducted the first randomised controlled trial of CBT for children and adolescents with anxiety disorders in Japan. Fifty‐one children and adolescents aged 8–15 with at least one diagnosis of an anxiety disorder were randomly allocated to either a CBT or a wait‐list control (WLC) condition.…”

Section: The Dissemination Of Cbt In Japanmentioning

confidence: 99%

The development, progress, and current status of cognitive behaviour therapy in Japan

Ishikawa

Chen

Fujisawa

et al. 2020

Australian Psychologist

View full text Add to dashboard Cite

This article reviewed the development, progress, current status, and future direction of cognitive behaviour therapy (CBT) in Japan. First, the history of CBT in Japan was briefly reviewed, including a description of the development of two major societies and their respective journals: the Japanese Association for Behaviour Therapy (later renamed as the Japanese Association for Behavioural and Cognitive Therapies) and the Japanese Association for Cognitive Therapy. Second, we reported on the existing evidence relating to CBT in Japan, including randomised control trials for depression, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and childhood anxiety disorders. Third, two established training systems for psychologists were outlined: (a) the National Training System for Cognitive Therapists, sponsored by the Ministry of Health, Labour and Welfare; and (b) Behavioural Therapy Specialists, qualified by the Japanese Association for Behavioural and Cognitive Therapies. We also reviewed the pathways to qualification as a clinical psychologist in Japan, undertaken through graduate training courses accredited by the Foundation of the Japanese Certification Board for Clinical Psychologists. Furthermore, we discuss the 2017 launch of the first national qualification standards, which has the potential to instigate dramatic change. Fourth, the impact and role of the national health insurance scheme in relation to psychological qualifications in Japan was described. Finally, future directions for cognitive behaviour therapy in Japan were discussed.

show abstract

A randomized controlled trial of a bidirectional cultural adaptation of cognitive behavior therapy for children and adolescents with anxiety disorders

Cited by 25 publications

References 36 publications

Practitioner Review: Anxiety disorders in children and young people – assessment and treatment

Practitioner Review: Anxiety disorders in children and young people – assessment and treatment

Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders – an international consensus statement

The development, progress, and current status of cognitive behaviour therapy in Japan

Contact Info

Product

Resources

About